findmyKOL

Peter Robertson, MD

Basic profile

Clinical Cardiac Electrophysiology

ORCIDNone on fileNPI
RegionMurfreesboro, TN · SoutheastSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2012Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Peter Robertson is a Cardiology physician. OpenAlex indexes 13 publications with 346 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13publications

Distinct works indexed by OpenAlex.

346citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
12companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1840 Medical Center Pkwy
Suite 201
Murfreesboro, TN 371292564

Telephone

615-867-5028

Registry record last updated 26 Sept 2014.

View the NPPES registry record

Industry payments

12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    64.5%
    Beta blocker20.4%
    Metoprolol Tartrate33%Metoprolol Succinate29%Carvedilol24%Sotalol5%Atenolol4%Nadolol3%Bisoprolol Fumarate2%
    Part D<11 patients
    Antiarrhythmic11.9%
    Flecainide Acetate34%Amiodarone Hcl29%Mexiletine Hcl21%Multaq11%Propafenone Hcl4%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    33.4%
    Factor Xa inhibitor29.7%
    Eliquis84%Xarelto16%
    Part D171 patients
    P2Y12 inhibitor1.7%
    Clopidogrel100%
    Part D15 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    2.1%
    Potassium supplement2.1%
    Potassium Chloride100%
    Part D21 patients
Where care is delivered (Part B)21.3% facility · 78.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”